P10.03 Establishment and validation of clinical prediction model in WHO grade II glioma

2021 ◽  
Vol 23 (Supplement_2) ◽  
pp. ii28-ii28
Author(s):  
X Xue ◽  
Q Gao

Abstract OBJECTIVE WHO grade II glioma has the characteristics of heterogeneity, and this disease progresses rapidly in some patients, in whom the malignant degree is equivalent to that of high-grade glioma. In order to accurately predict the prognosis of patients, an effective clinical prediction model based on relevant risk factors is needed which could provide a theoretical basis for optimization of clinical individualized treatment. METHODS According to the inclusion and exclusion criteria, eligible patients from January 2010 to December 2018 in our hospital were selected, and those who met the criteria were randomly assigned 4:1 to the training group and the validation group, respectively. The predictors were screened by univariate and multivariate Cox regression analysis, the prediction model was established, and the model was verified and evaluated. RESULTS A total of 258 patients with WHO grade II glioma were recruited, including 208 patients as the training group and 50 patients as the validation group. Six independent risk factors, including patient age, preoperative Karnofsky performance status (KPS) score, preoperative seizure symptoms, surgical resection range, tumor size and IDH status, were selected and included into the prediction model by univariate and multivariate Cox regression analysis, and were visualized in the form of Nomogram. The concordance index (C index) was used to evaluate the predictive ability of the model. Results showed that the C-index was 0.832 in the training group and 0.853 in the validation group, respectively, indicating good performance for the prediction model. The calibration charts were drawn in both groups respectively, which showed that the calibration lines were in good agreement with the standard lines, indicating good consistency between the two groups. CONCLUSIONS In this study, a clinical prediction model for WHO grade II glioma was established, and it was verified that the model has good predictive ability, which may be beneficial for clinical work.

2014 ◽  
Vol 117 (1) ◽  
pp. 25-32 ◽  
Author(s):  
J. Blaes ◽  
M. Weiler ◽  
F. Sahm ◽  
B. Hentschel ◽  
M. Osswald ◽  
...  

2010 ◽  
Vol 153 (3) ◽  
pp. 473-477 ◽  
Author(s):  
Hugues Duffau ◽  
Johan Pallud ◽  
Emmanuel Mandonnet

2008 ◽  
Vol 31 (3) ◽  
pp. 263-269 ◽  
Author(s):  
Emmanuel Mandonnet ◽  
Johan Pallud ◽  
Olivier Clatz ◽  
Luc Taillandier ◽  
Ender Konukoglu ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0144200 ◽  
Author(s):  
Sarah Parisot ◽  
Amélie Darlix ◽  
Cédric Baumann ◽  
Sonia Zouaoui ◽  
Yordanka Yordanova ◽  
...  

2009 ◽  
Vol 33 (1) ◽  
pp. 91-96 ◽  
Author(s):  
Emmanuel Mandonnet ◽  
Johan Pallud ◽  
Denys Fontaine ◽  
Luc Taillandier ◽  
Luc Bauchet ◽  
...  

2017 ◽  
Vol 19 (suppl_6) ◽  
pp. vi55-vi56
Author(s):  
Marco Timmer ◽  
Gabriele Röhn ◽  
Roland Goldbrunner ◽  
Jan Werner

2016 ◽  
Vol 124 (1) ◽  
pp. 141-145 ◽  
Author(s):  
Jérôme Cochereau ◽  
Guillaume Herbet ◽  
Valérie Rigau ◽  
Hugues Duffau

WHO Grade II glioma (low-grade glioma [LGG]) is increasingly diagnosed as an incidental finding in patients undergoing MRI for many conditions. Recent data have demonstrated that such incidental LGGs are progressive tumors that undergo clinical transformation and ultimately become malignant. Although asymptomatic LGG seems to represent an earlier step in the natural course of a glioma than the symptomatic LGG, it is nonetheless impossible to predict at the individual level when the tumor will become malignant. The authors report the case of a 43-year-old woman with a right operculo-insular LGG that was incidentally diagnosed because of headaches. No treatment was proposed, and repeated MRI scans were performed for 6 years in another institution. Due to a slow but continuous growth of the lesion, the patient was finally referred to our center to undergo surgery. Interestingly, objective calculation of the velocity of the tumor’s diametric expansion demonstrated a sudden acceleration of the growth rate within the 5 months preceding surgery, with the development of contrast enhancement. Remarkably, the patient was still asymptomatic. An awake resection was performed with intraoperative electrical mapping. There was no functional worsening following surgery, as assessed on postoperative neuropsychological examination. Removal of 92% of signal abnormality on FLAIR MRI was achieved, with complete resection of the area of contrast enhancement. Neuropathological examination revealed a glioblastoma, and the patient was subsequently treated with concomitant radiotherapy and chemotherapy. Although a “wait and see” attitude has been advocated by some authors with respect to incidental LGG, our original case demonstrates that acute transformation to glioblastoma may nonetheless occur, even before the onset of any symptoms. Therefore, because the lack of symptoms does not protect from malignant transformation, we propose consideration of earlier resection in a more systematic manner in cases of incidental LGG.


Sign in / Sign up

Export Citation Format

Share Document